Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

FR-167653 suppresses cytokine levels and exerts cardioprotective effects in rat model of CHF

June 28, 2002

BiDil to be evaluated in African American heart failure population

June 27, 2002

Sphingosine kinase inhibitor and its use in restenosis, etc.

June 26, 2002

Texas Biotechnology claims alpha4beta1 antagonists for atherosclerosis and other conditions

June 26, 2002

MediGene discontinues development of candidate for heart failure

June 26, 2002

GW-3965, a synthetic LXR ligand, displays potent antiatherogenic activity

June 21, 2002

Tulane and Biomeasure team claims urotensin-II antagonists

June 19, 2002

Antioxidant and cardioprotective effects of resveratrol and astringinin

June 18, 2002

cGMP-selective PDE inhibitors in early development at Nippon Soda

June 18, 2002

FDA advisory committee sets date to review Vanlev

June 17, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...